Big chase for a cancer drug: The urgent need for affordable Keytruda alternatives

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, Indian companies are developing more affordable versions. Efforts are also focused on expanding indications and improving financial access.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Qq2VPOL
via IFTTT